SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-011434
Filing Date
2023-08-31
Accepted
2023-08-31 17:16:13
Documents
16
Period of Report
2023-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cvm_8k.htm   iXBRL 8-K 22794
2 EXTENSION OF EMPLOYMENT AGREEMENT cvm_ex1010.htm EX-10.10 3112
3 EXTENSION OF EMPLOYMENT AGREEMENT cvm_ex1011.htm EX-10.11 4036
  Complete submission text file 0001654954-23-011434.txt   141955

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cvm-20230828.xsd EX-101.SCH 5712
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20230828_lab.xml EX-101.LAB 12618
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20230828_cal.xml EX-101.CAL 895
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20230828_pre.xml EX-101.PRE 7878
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20230828_def.xml EX-101.DEF 2096
10 EXTRACTED XBRL INSTANCE DOCUMENT cvm_8k_htm.xml XML 3160
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 231229447
SIC: 2836 Biological Products, (No Diagnostic Substances)